Qaelum
We are a fast-growing spin-off company from the University Hospitals Leuven and are passionate about solving real-world problems. This is why we develop highly innovative solutions for everyday problems in medical imaging environments. Our solutions aim to improve the quality and efficiency of radiology departments around the world. We are located in Leuven, but our products are implemented in medical facilities all over Europe, the Middle East and Asia. In 2016 we endeavoured to internationalize even more and established our presence in the U.S through opening offices in New York. Ensuring top-notch quality remains our foremost commitment. Hence, our quality management system adheres to ISO 13485:2016 standards for Medical Devices. Qaelum also proudly holds ISO 27001:2022 certification for Information Security. Additionally, our medical device tools are certified as CE 1639 class IIb.
PZ Medical Technology Co Ltd
Pure Storage
The top healthcare innovators rely on Pure Storage to redefine the storage experience and simplify how people consume and interact with data. Pure’s fast and future-ready storage transforms data into value across the entire healthcare enterprise. Pure powers the EHRs, enterprise imaging, back-office systems and more with storage that delivers 99.9999% uptime and robust data protection. Storage as you need it is the Pure way, whether it’s on-premises, in the cloud, a hybrid model, or as a service. No more “click and wait” for clinical answers. No more disruptive data storage upgrades. Just quicker insights for better patient care. Purestorage.com/healthcare | The top healthcare innovators rely on Pure Storage to redefine the storage experience and simplify how people consume and interact with data. Pure’s fast and future-ready storage means no more “click and wait” for clinical answers. No more disruptive data storage upgrades. Just quicker insights for better patient care. Purestorage.com/healthcare
PulManage, Inc.
PulManage, Inc is a software company specializing in remote monitoring of chronic lung disease such as COPD. The proprietary platform utilizes a mobile application to collect spirometry data from a handheld medical device and push that information directly into a secure, web-based application for patients to document symptoms and respiratory function. Simultaneously, providers can survey and trend the patient’s condition remotely. The platform can be utilized to create value and document physiologic and therapeutic response longitudinally. | PulManage, Inc., a digital health company, has developed a platform for chronic lung disease that pairs with FDA-approved lung-function devices. The platform provides critical lung-function data coupled with symptom management and respiratory biomarkers for patients and medical teams in a secure portal. The system allows medical providers and clinical researchers to survey respiratory status remotely. The company is developing predictive algorithms using AI to better understand disease patterns and mitigate risk. More than 24 million people in the United States live with chronic lung diseases such as COPD or asthma. When combined with lung cancer and respiratory diseases like COVID-19 or influenza, lung disease is the number one cause of death by disease in America. | PulManage, Inc. is transforming respiratory clinical trials in rare diseases by solving persistent challenges like data variability, patient recruitment, and operational inefficiencies. Traditional in-person spirometry is burdensome and technician-dependent, leading to low data fidelity. PulManage’s compliant, scalable platform provides real-time, high-quality remote spirometry guided by credentialed respiratory therapists, reducing variability by up to 40% and ensuring global ATS/ERS compliance. Frequent, standardized assessments and real-time analytics enhance data fidelity and disease characterization. Shared dashboards improve sponsor oversight. Proven in rural COPD studies, the platform boosts enrollment, communication, and data quality. It’s used by academic centers and a rare disease community for trials and real-world evidence, with future support for multilingual trials, wearables, and forecasting analytics.
PTW / QRM
For 100 years, PTW has set the mark in making radiation safer – through breakthrough dosimetry products and an uncompromising commitment to quality, safety and knowledge. Today, we are a major global player in the dosimetry market with a large portfolio of long-established product brands, many of them used around the world for decades. PTW technologies enable clinical radiation experts in over 160 countries worldwide to precisely monitor highly complex clinical radiation equipment. As a pioneer in medical radiation measurements, PTW also operates one of the oldest and largest SSDL calibration laboratories and established THE DOSIMETRY SCHOOL to promote the exchange of knowledge in clinical dosimetry. QRM, a PTW company, has more than 25 years’ experience developing phantoms to evaluate, analyze and tune the performance of medical imaging devices, with a strong focus on diagnostic X-ray, CT and micro-CT imaging, as well as dosimetry.
PTW Freiburg GmbH
Prysmian
Prysmian is a global cable solutions provider leading the energy transition and digital transformation. By leveraging its wide geographical footprint and extensive product range, its track record of technological leadership and innovation, and a strong customer base, the company is well-placed to capitalize on its leading positions and win in new and growing markets. Prysmian’s business strategy perfectly matches key market drivers by developing resilient, high-performing, sustainable and innovative cable solutions in the segments of Transmission, Power Grid, Electrification and Digital Solutions. Prysmian is a public company listed on the Italian Stock Exchange, with almost 150 years of experience, over 33,000 employees, 107 plants and 27 R&D centers in over 50 countries, and over €17 billion of revenues in 2024.
pRxEngage
Have you ever felt like finding the right clinical trial is as complex as online dating, but without the fun swiping? At pRxEngage, we are revolutionising how patients and pioneering research connect, making the process as intuitive and empowering as finding your perfect match! The current scene in clinical trials is often slow, incredibly expensive, and frankly, fails both sponsors and the very patients it aims to help. While over 80% of patients are eager to join trials, a mere 30% actually do. This massive disconnect means trials are frequently delayed, racking up costs of £420,000 to over £6 million per day, and vital new drugs are stuck in development. We are here to change that. pRxEngage goes beyond simply recruiting; we’re about deep, sustained engagement. We look past just medical suitability to address whether a trial truly fits into a person’s life, helping them overcome any doubts. By making patients active ‘consumers’ of the trial, opting in at each stage, we build an ever-deepening relationship. The outcome? Better retention, greater adherence, and faster trial success. Our platform makes finding a trial as simple as swiping right or left. Our AI-powered system guides patients with easy-to-understand, jargon-free information and tools based on behavioural science, like Self-Determination Theory, to help them assess their suitability. Then, it seamlessly connects them directly to trial sites. For sponsors and sites, we provide real-time data dashboards and predictive analytics to identify suitable participants and improve retention. Our AI even helps streamline trial setup by parsing documents and generating clear summaries for participants. pRxEngage is engineered to redefine the connection between high-potential patients and appropriate clinical trials, accelerating crucial enrolment timelines. We foster sustained participant engagement, moving beyond conventional recruitment metrics to cultivate a more committed and informed cohort from the outset. This results in a higher-calibre, more dedicated participant pool from the initial stages, directly contributing to improved trial success rates, enhanced participant retention, and greater adherence to study protocols. We are truly unique because we combine community partnerships, predictive engagement, and operational support. We work with patients, sites, sponsors, charities, and patient organisations, building trust and integrating feedback. Our predictive tools identify engaged participants, and our operational support offers workflow and triage tools for sites and sponsors to boost efficiency. We are an additive solution, meaning we work alongside existing sponsor tools, making adoption easy. We are proud to be developing groups of community partners and ambassadors. This includes fantastic organisations like PiCC Unite, The PBC Foundation, and Don’tBePatient, with several more in advanced development. These collaborations are crucial to our mission of broadening awareness and access to research opportunities, ensuring that value and information remain within these communities. Our success springs from our visionary leadership and proven execution. Our Founder and CEO, Keith Berelowitz, brings over two decades of experience, having brought 12 drugs to market and achieved top-enrolling site status in numerous multi-centre trials. Charlie Myrick, our CTO, is a founding CTO with a background in architecting global engineering solutions and building HIPAA-certified SaaS patient tracking systems. Ethan Graff-Radford, our Head of Product, has experience in product management at an A16Z-backed company and has implemented agile methodologies for health-tech solutions. Our board members, David Guthrie and Daniel Graff-Radford, bring decades of experience shaping health-tech, scaling companies, and providing strategic technological oversight. This combined expertise means pRxEngage represents the convergence of profound clinical trial operational knowledge with sophisticated technological execution. Our intellectual property strategy focuses on our registered trademark for the pRxEngage brand, which is crucial for establishing our identity as we turn clinical trial interest into action. Beyond branding, we rely significantly on trade secrets to protect our unique algorithms, data analytics methodologies, behavioural science integration, and operational workflows. These elements fundamentally change the focus from mere recruiting to long-term patient engagement, retention, and measurable return on investment. Want to learn more about how pRxEngage is changing the game for clinical trials? Check out our company one-pager (https://docsend.com/v/y95hx/swiperightonresearch) and read our recent blog (https://docsend.com/v/y95hx/makingpatientfirstmeansomethingbeyondconsent) post to see our thinking in action. #pRxEngaged #GetpRxEngaged #ClinicalTrials #PatientEngagement #HealthcareInnovation #MedTech #ClinicalResearch
Providence
At Providence, we take time to see, hear and value everyone who walks through our doors. Working with us means that regardless of your role, we’ll walk alongside you in your career, supporting you so you can support others. | At Providence, our strength begins with understanding. We take time to see, hear and value everyone who walks through our doors. Working with us means that regardless of your role, we’ll walk alongside you in your career, supporting you so you can support others. Together, our 120,000 caregivers (all employees) serve in 51 hospitals, 1,085 clinics and a comprehensive range of health and social services across Alaska, California, Montana, New Mexico, Oregon, Texas and Washington. https://youtu.be/LqAyo26fvDg Our commitment to diversity and inclusion: Diversity Equity and Inclusion (DEI) is central to our Mission. We engage in ongoing, robust recruitment practices for all levels and departments to bring the best and brightest talent to our family of organizations, prioritizing diversity in race, culture, gender identity or expression and sexual orientation, background, experience, talent and thought. We foster an inclusive workplace where caregivers of differing backgrounds and perspectives can experience a community of mutual respect, inclusivity and collegiality, and know unequivocally that diversity is valued. Benefits and rewards: You are valued as a Providence caregiver. You strive towards health for all every day, and we value that drive to achieve. In return, we do everything we can to support you and your family. Learn more about our benefits. The Providence family includes: • Providence across five western states • Covenant Health in West Texas • Facey Medical Foundation in Los Angeles, CA • Kadlec in Southeast Washington • Pacific Medical Centers in Seattle, WA • Providence Swedish in Puget Sound area, WA As a comprehensive health care organization, we are serving more people, advancing best practices and continuing our more than 100-year tradition of serving the poor and vulnerable. Delivering services across seven states, Providence is committed to touching millions of more lives and enhancing the health of the American West to transform care for the next generation and beyond. View all current career opportunities at providence.jobs.
PROTEOGENIX
With over 20 years of expertise, ProteoGenix is a leading life sciences company providing integrated solutions to public and private research laboratories worldwide. We specialize in accelerating biological projects through high-quality reagents and strategic partnerships. Our core solutions include: – Custom Antibody Production: We deliver tailored monoclonal and polyclonal antibodies. Our custom antibody services ensure high specificity and affinity for even the most complex targets. -> https://www.proteogenix.science/custom-antibody/ – Recombinant Antibody Services: We provide advanced engineering and production to ensure total reproducibility and scalability for therapeutic or diagnostic applications. – Custom Cell Line Development: We design stable, high-yield cell lines optimized for protein expression and functional assays. – Protein & Peptide Synthesis: From gene synthesis to final production, we provide comprehensive support for all your molecular biology needs. ProteoGenix also offers an extensive catalog of antibodies, proteins, ELISA kits, and Tissue Microarrays. By combining deep scientific knowledge with remarkable functional know-how, we guarantee reliable tools and rapid turnaround times. Partner with ProteoGenix to transform your research into groundbreaking results. | ProteoGenix is a leading antibody production company founded in 2003. Our integrated solutions from gene to biotherapeutics & diagnostics make us the preferred partner of pharmaceutical & biotech companies for assay and therapeutic antibody development. | ProteoGenix is a France and USA-based biotech contract research organization (CRO) providing flexible end-to-end solutions for the discovery and development of life-saving biologics, precision diagnostic tools, and high-quality reagents. As a global leader in antibody, protein, peptide, and gene production, ProteoGenix aims at fostering the development of next-generation immunotherapies and immunoassays.